Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

A Swedish study shows that the risk for cardiovascular diseases is elevated in patients with chronic hypoparathyroidism, ...

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (LeroChol®), a ...

A scientific statement has been published by the American Heart Association regarding the effect of sleep health on cardiometabolic health.

Solomon Partners Securities, LLC acted as financial advisor to Lantheus in this transaction, while Foley Hoag LLP and Ropes & Gray LLP acted as legal advisors, and Ernst & Young LLP acted as financial ...

Optimized perioperative fluid management, may help mitigate the risk of Postoperative urinary retention (POUR) suggests a new ...

Wearable devices offer a promising alternative. Cost-effective, scalable, and non-invasive, they can continuously collect ...

When an undiagnosed illness leads to an outbreak, there is a tendency to call it a ‘mystery disease’. Experts say this ...

Women of childbearing age who had both ovaries removed, in a procedure called bilateral oophorectomy, were more likely to ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today reported financial results for the first quarter ended March 31, 2025, and provided a business update.

A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people ...